TG Therapeutics

NCT04016805

Phase 2, Terminated, 2019, 41 people, 11 Jul 2019, clinicaltrials.gov

NCT03801525

Phase 2/3, Terminated, 2019, 277 people, 11 Jan 2019, clinicaltrials.gov

NCT03379051

Phase 1/2, Terminated, 2018, 78 people, 20 Dec 2017, clinicaltrials.gov

NCT02574663

Phase 1, Completed, 2015, 66 people, 14 Oct 2015, clinicaltrials.gov

NCT02301156

Phase 3, Completed, 2015, 126 people, 25 Nov 2014, clinicaltrials.gov

NCT02268851

Collaborator, Phase 1, Completed, 2014, 45 people, 20 Oct 2014, clinicaltrials.gov

NCT02013128

Phase 1/2, Completed, 2014, 66 people, 17 Dec 2013, clinicaltrials.gov

NCT02006485

Phase 1, Completed, 2013, 160 people, 10 Dec 2013, clinicaltrials.gov